A new study suggests that a compound found in “magic mushrooms” may help treat depression by reducing specific brain activity that traps individuals in persistent negative thought patterns.
Depression affects hundreds of millions of people worldwide and is typically characterized by prolonged feelings of sadness, a lack of pleasure, and loss of interest in daily activities for most of the day over several weeks.
To manage the condition, patients are commonly prescribed talk therapy and antidepressant medications. However, research shows that these treatments are not effective for everyone, and the reasons why many patients remain stuck in depressive states for long periods are still not fully understood.
In recent years, psilocybin — a naturally occurring compound found in magic mushrooms — has been widely studied for its antidepressant properties. Researchers have observed that even a single dose can produce long-lasting changes in brain function.
The latest study sheds light on how psilocybin may work to alleviate depression. According to scientists at Cornell University, the compound weakens a specific type of brain activity associated with “rumination,” a process in which individuals become trapped in repetitive, negative thoughts.
Writing in the journal Cell, lead author Alex Kwan explained that rumination is one of the core features of depression, describing it as a mental state where people continuously cycle through the same distressing thoughts.
Researchers believe that by disrupting this harmful loop, psilocybin may help patients break free from persistent negative thinking, offering new hope for more effective depression treatments in the future.
